Rheumatoid Arthritis

Study comparing an investigational medication versus (Humira) in patients with active rheumatoid arthritis (RA).  Total duration of subject participation will be approximately 58 weeks.

Study medication and all study related costs as well as a stipend will be provided.

Patients who are eligible:
– are between 18 and 80 years of age
– have had moderately to severely active rheumatoid arthritis for at least 6 months
– are taking a medication for their rheumatoid arthritis called methotrexate
– have not taken Humira in the past